https://orcid.org/0000-0002-5404-5808
References
- Navarrete F, García-Gutiérrez MS, Gasparyan A, Austrich-Olivares A, Manzanares J. Role of Cannabidiol in the therapeutic intervention for substance use disorders. Front Pharmacol. 2021;12. doi:https://doi.org/10.3389/fphar.2021.626010.
- Liu L, Li J, Wang C, Xu Y, Leung C, Yang G, Lin S, Zhang S, Tan Y, Zhang H, et al. Cannabidiol attenuates methamphetamine-induced conditioned place preference in male rats and viability in PC12 cells through the Sigma1R/AKT/GSK3 β/CREB signaling pathway. 2022. doi:10.1080/00952990.2022.2073450.
- Sambo DO, Lin M, Owens A, Lebowitz JJ, Richardson B, Jagnarine DA, Shetty M, Rodriquez M, Alonge T, Ali M, et al. The sigma-1 receptor modulates methamphetamine dysregulation of dopamine neurotransmission. Nat Commun. 2017;8. doi:10.1038/S41467-017-02087-X.
- Stefanski R, Justinova Z, Hayashi T, Takebayashi M, Goldberg SR, Su TP. Sigma1 receptor upregulation after chronic methamphetamine self-administration in rats: a study with yoked controls. Psychopharmacology (Berl). 2004;175:68–75. doi:10.1007/s00213-004-1779-9.
- Chao J, Zhang Y, Du L, Zhou R, Wu X, Shen K, Yao H. Molecular mechanisms underlying the involvement of the sigma-1 receptor in methamphetamine-mediated microglial polarization. Sci Rep. 2017;7. doi:10.1038/S41598-017-11065-8.
- Yao H, Yang Y, Kim KJ, Bethel-Brown C, Gong N, Funa K, Gendelman HE, Su TP, Wang JQ, Buch S. Molecular mechanisms involving sigma receptor–mediated induction of MCP-1: implication for increased monocyte transmigration. Blood. 2010;115:4951–62. doi:10.1182/BLOOD-2010-01-266221.
- Yang G, Liu L, Zhang R, Li J, Leung C-K, Huang J, Li Y, Shen B, Zeng X, Zhang D. Cannabidiol attenuates methamphetamine-induced conditioned place preference via the Sigma1R/AKT/GSK-3β/CREB signaling pathway in rats. Toxicol Res (Camb). 2020;9:202–11. doi:10.1093/toxres/tfaa021.
- Karimi-Haghighi S, Haghparast A. Cannabidiol inhibits priming-induced reinstatement of methamphetamine in REM sleep deprived rats. Prog Neuro-Psychopharmacol Biol Psychiatry. 2018;82:307–13. doi:10.1016/j.pnpbp.2017.08.022.
- Hay GL, Baracz SJ, Everett NA, Roberts J, Costa PA, Arnold JC, McGregor IS, Cornish JL. Cannabidiol treatment reduces the motivation to self-administer methamphetamine and methamphetamine-primed relapse in rats. J Psychopharmacol. 2018;32:1369–78. doi:10.1177/0269881118799954.